CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells (Q75357565)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

7

Barbara Seliger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Jan Alvar Lindencrona

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Susanne Preiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Thomas Kammertoens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Thomas Schüler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Marie Piechocki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Wei-Zen Wei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Thomas Blankenstein

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Rolf Kiessling

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

English

0 references

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

17 November 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

259-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice

17 November 2019

cites work

1 reference

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

21 January 2018

1 reference

Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials

21 January 2018

1 reference

An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

21 January 2018

1 reference

Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat

21 January 2018

1 reference

Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA.

21 January 2018

1 reference

Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA.

21 January 2018

1 reference

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

Tumor rejection by disturbing tumor stroma cell interactions

21 January 2018

1 reference

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice

21 January 2018

1 reference

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.11654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14750178%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference